HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycans

Development

Volumn 137, Issue 13, 2010, Pages 2205-2214

  Iwamoto, Ryo ^a   Mine, Naoki ^a   Kawaguchi, Taichiro ^a   Minami, Seigo ^a   Saeki, Kazuko ^b   Mekada, Eisuke ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

HB EGF (HBEGF); HSPGs; Mouse; Valvulogenesis

Indexed keywords

HEPARIN BINDING EPIDERMAL GROWTH FACTOR;

ARTICLE; CELL PROLIFERATION; EX VIVO STUDY; HEART DEVELOPMENT; HEART VALVE; MESENCHYME CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; CELL PROLIFERATION; ENDOCARDIAL CUSHIONS; HEART VALVES; HEPARAN SULFATE PROTEOGLYCANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESODERM; MICE;

MUS;

EID: 77953314365     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.048926     Document Type: Article

References (42)

1. Armstrong, E. J. and Bischoff, J. (2004). Heart valve development: endothelial cell signaling and differentiation. Circ. Res. 95, 459-470.
2. Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J. and Zako, M. (1999). Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729-777.
3. Bishop, J. R., Schuksz, M. and Esko, J. D. (2007). Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030-1037.
4. Camenisch, T. D., Schroeder, J. A., Bradley, J., Klewer, S. E. and McDonald, J. A. (2002). Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat. Med. 8, 850-855.
5. Chen, B., Bronson, R. T., Klaman, L. D., Hampton, T. G., Wang, J. F., Green, P. J., Magnuson, T., Douglas, P. S., Morgan, J. P. and Neel, B. G. (2000). Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat. Genet. 24, 296-299.
6. Costell, M., Carmona, R., Gustafsson, E., González-Iriarte, M., Fässler, R. and Muñoz-Chápuli, R. (2002). Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ. Res. 91, 158-164.
7. Eisenberg, L. M. and Markwald, R. R. (1995). Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 77, 1-6.
8. Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J. and Leung, D. W. (1991). The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47, 211-218.
9. Goishi, K., Higashiyama, S., Klagsbrun, M., Nakano, N., Umata, T., Ishikawa, M., Mekada, E. and Taniguchi, N. (1995). Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell 6, 967-980.
10. Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C. and Klagsbrun, M. (1991). A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251, 936-939. (Pubitemid 21926188)
11. Higashiyama, S., Lau, K., Besner, G. E., Abraham, J. A. and Klagsbrun, M. (1992). Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J. Biol. Chem. 267, 6205-6212.
12. Higashiyama, S., Abraham, J. A. and Klagsbrun, M. (1993). Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J. Cell Biol. 122, 933-940. (Pubitemid 23241102)
13. Higashiyama, S., Iwamoto, R., Goishi, K., Raab, G., Taniguchi, N., Klagsbrun, M. and Mekada, E. (1995). The membrane protein CD9/DRAP27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J. Cell Biol. 128, 929-938.
14. Iwamoto, R. and Mekada, E. (2000). Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 11, 335-344.
15. Iwamoto, R. and Mekada, E. (2006). ErbB and HB-EGF signaling in heart development and function. Cell Struct. Funct. 31, 1-14.
16. Iwamoto, R., Handa, K. and Mekada, E. (1999). Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J. Biol. Chem. 274, 25906-25912. (Pubitemid 129530772)
17. Iwamoto, R., Yamazaki, S., Asakura, M., Takashima, S., Hasuwa, H., Miyado, K., Adachi, S., Kitakaze, M., Hashimoto, K., Raab, G. et al. (2003). Heparinbinding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. USA 100, 3221-3226.
18. Jackson, L. F., Qiu, T. H., Sunnarborg, S. W., Chang, A., Zhang, C., Patterson, C. and Lee, D. C. (2003). Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 22, 2704-2716.
19. Kimura, R., Iwamoto, R. and Mekada, E. (2005). Soluble form of heparinbinding EGF-like growth factor contributes to retinoic acid-induced epidermal hyperplasia. Cell Struct. Funct. 30, 35-42.
20. Lakkis, M. M. and Epstein, J. A. (1998). Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development 125, 4359-4367.
21. Lamers, W. H., Viragh, S., Wessels, A., Moorman, A. F. and Anderson, R. H. (1995). Formation of the tricuspid valve in the human heart. Circulation 91, 111-121.
22. Lin, X. and Perrimon, N. (2002). Developmental roles of heparan sulfate proteoglycans in Drosophila. Glycoconj. J. 19, 363-368.
23. Lortat-Jacob, H., Kleinman, H. K. and Grimaud, J. A. (1991). High-affinity binding of interferon-gamma to a basement membrane complex (matrigel). J. Clin. Invest. 87, 878-883.
24. Lyon, M., Rushton, G. and Gallagher, J. T. (1997). The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoformspecific. J. Biol. Chem. 272, 18000-18006.
25. Mekada, E. and Iwamoto, R. (2008). HB-EGF. UCSD-Nature Molecule Pages. doi:10.1038/mp.a002932.01.
26. Minami, S., Iwamoto, R. and Mekada, E. (2008). HB-EGF decelerates cell proliferation synergistically with TGFα in perinatal distal lung development. Dev. Dyn. 237, 247-258.
27. Mine, N., Iwamoto, R. and Mekada, E. (2005). HB-EGF promotes epithelial cell migration in eyelid development. Development 132, 4317-4326.
28. Perrimon, N. and Bernfield, M. (2000). Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404, 725-728.
29. Raab, G. and Klagsbrun, M. (1997). Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta 1333, F179-F199.
30. Rapraeger, A. C. (1995). In the clutches of proteoglycans: how does heparan sulfate regulate FGF binding? Chem. Biol. 2, 645-649.
31. Roberts, R., Gallagher, J., Spooncer, E., Allen, T. D., Bloomfield, F. and Dexter, T. M. (1988). Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 332, 376-378.
32. Schroeder, J. A., Jackson, L. F., Lee, D. C. and Camenisch, T. D. (2003). Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J. Mol. Med. 81, 392-403.
33. Shirakata, Y., Kimura, R., Nanba, R., Iwamoto, R., Tokumaru, S., Morimoto, C., Yokota, K., Nakamura, M., Sayama, K., Mekada, E. et al. (2005). Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J. Cell Sci. 118, 2363-2370.
34. Shishido, Y., Sharma, K. D., Higashiyama, S., Klagsbrun, M. and Mekada, E. (1995). Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparinbinding epidermal growth factor-like growth factor. J. Biol. Chem. 270, 29578-29585.
35. Takazaki, R., Shishido, Y., Iwamoto, R. and Mekada, E. (2004). Suppression of the biological activities of the epidermal growth factor (EGF)-like domain by the heparin-binding domain of heparin-binding EGF-like growth factor. J. Biol. Chem. 279, 47335-47343.
36. Utriainen, A., Sormunen, R., Kettunen, M., Carvalhaes, L. S., Sajanti, E., Eklund, L., Kauppinen, R., Kitten, G. T. and Pihlajaniemi, T. (2004). Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Hum. Mol. Genet. 13, 2089-2099.
37. Wang, X., Mizushima, H., Adachi, S., Ohishi, M., Iwamoto, R. and Mekada, E. (2006). Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor. Cell Struct. Funct. 31, 15-27.
38. Xie, H., Wang, H., Tranguch, S., Iwamoto, R., Mekada, E., DeMayo, F. J., Lydon, J. P., Das, S. K. and Dey, S. K. (2007). Maternal heparin-binding-EGF deficiency limits pregnancy success in mice. Proc. Natl. Acad. Sci. USA 104, 18315-18320.
39. Yagi, T., Tokunaga, T., Furuta, Y., Nada, S., Yoshida, M., Tsukada, T., Saga, Y., Takeda, N. and Aizawa, S. (1993). A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214, 70-76.
40. Yamazaki, S., Iwamoto, R., Saeki, K., Asakura, M., Takashima, S., Yamazaki, A., Kimura, R., Mizushima, H., Moribe, H., Higashiyama, S. et al. (2003). Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J. Cell Biol. 163, 469-475.
41. Zcharia, E., Metsger, S., Chajec-Shaul, T., Aingorn, H., Elkin, M., Friedmann, Y., Weinstein, T., Li, J. P., Lindahl, U. and Vlodavsky, I. (2004). Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J. 18, 252-263.
42. Zcharia, E., Jia, J., Zhang, X., Baraz, L., Lindahl, U., Perets, T., Vlodavsky, I. and Li, J. P. (2009). Newly generated heparanase knock-out mice unravel coregulation of heparanase and matrix metalloproteinases. PLoS ONE 4, e5181.